For: | Zhang CY, Liu S, Yang M. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World J Gastrointest Oncol 2022; 14(8): 1456-1468 [PMID: 36160747 DOI: 10.4251/wjgo.v14.i8.1456] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i8/1456.htm |
Number | Citing Articles |
1 |
Chunye Zhang, Jiazheng Liu, Yuxiang Sui, Shuai Liu, Ming Yang. In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48398-6
|
2 |
Jian Yang, Ying Liu, Shi Liu. Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”. World Journal of Gastrointestinal Oncology 2023; 15(2): 368-371 doi: 10.4251/wjgo.v15.i2.368
Abstract(362) |
Core Tip(346) |
Full Article(HTML)(1234)
|
Full Article (PDF)-612K(117)
|
Full Article (Word)-106K(35)
|
Audio-10889K(9)
|
Peer-Review Report-236K(47)
|
Answering Reviewers-299K(48)
|
Times Cited (0)
|
Total Visits (4384)
|
Open
|
3 |
Falak Zeb, Huma Naqeeb, Tareq Osaili, MoezAllslam Ezzat Faris, Leila Cheikh Ismail, Reyad Shakir Obaid, Farah Naja, Hadia Radwan, Hayder Hasan, Mona Hashim, Sharifa AlBlooshi, Iftikhar Alam. Molecular crosstalk between polyphenols and gut microbiota in cancer prevention. Nutrition Research 2024; 124: 21 doi: 10.1016/j.nutres.2024.01.012
|
4 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
|
5 |
Chengxiang Fang, Haiyan Sun, Jing Wen, Xuehu Wu, Qian Wu, Dongsheng Zhai. Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches. Medicine 2024; 103(31): e39057 doi: 10.1097/MD.0000000000039057
|
6 |
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies. Pharmaceuticals 2023; 16(10): 1479 doi: 10.3390/ph16101479
|
7 |
Elena Petersen, Daria Chudakova, Daiana Erdyneeva, Dulamsuren Zorigt, Evgeniya Shabalina, Pavel Karalkin, Igor Reshetov. Cancer as a potential sequela of COVID-19 — should we modify 3D cell culture models accordingly?. Biological Communications 2023; 68(3) doi: 10.21638/spbu03.2023.307
|
8 |
Ming Yang, Shuai Liu, Chunye Zhang. The Related Metabolic Diseases and Treatments of Obesity. Healthcare 2022; 10(9): 1616 doi: 10.3390/healthcare10091616
|
9 |
Vanessa G. P. Souza, Aisling Forder, Michelle E. Pewarchuk, Nikita Telkar, Rachel Paes de Araujo, Greg L. Stewart, Juliana Vieira, Patricia P. Reis, Wan L. Lam. The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression. Cells 2023; 12(24): 2801 doi: 10.3390/cells12242801
|
10 |
Jian Yang, Ying Liu, Shi Liu. Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”. World Journal of Gastrointestinal Oncology 2023; 15(2): 367 doi: 10.4251/wjgo.v15.i2.367
|
11 |
Maria Bogdan, Andreea-Daniela Meca, Adina Turcu-Stiolica, Carmen Nicoleta Oancea, Roxana Kostici, Marin Valeriu Surlin, Cristina Florescu. Insights into the Relationship between Pentraxin-3 and Cancer. International Journal of Molecular Sciences 2022; 23(23): 15302 doi: 10.3390/ijms232315302
|